Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stryker Corp (SYK)

Stryker Corp (SYK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,465,824
  • Shares Outstanding, K 380,950
  • Annual Sales, $ 20,498 M
  • Annual Income, $ 3,165 M
  • 60-Month Beta 0.91
  • Price/Sales 6.61
  • Price/Cash Flow 26.35
  • Price/Book 6.81
Trade SYK with:

Options Overview Details

View History
  • Implied Volatility 27.59% ( +0.80%)
  • Historical Volatility 13.73%
  • IV Percentile 91%
  • IV Rank 62.41%
  • IV High 34.86% on 10/13/23
  • IV Low 15.51% on 05/17/24
  • Put/Call Vol Ratio 1.76
  • Today's Volume 367
  • Volume Avg (30-Day) 979
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 33,782
  • Open Int (30-Day) 33,511

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.78
  • Number of Estimates 13
  • High Estimate 2.96
  • Low Estimate 2.75
  • Prior Year 2.46
  • Growth Rate Est. (year over year) +13.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
343.95 +3.39%
on 10/07/24
374.63 -5.08%
on 09/16/24
-10.75 (-2.93%)
since 09/11/24
3-Month
314.93 +12.91%
on 08/05/24
374.63 -5.08%
on 09/16/24
+17.51 (+5.18%)
since 07/11/24
52-Week
249.98 +42.25%
on 10/13/23
374.63 -5.08%
on 09/16/24
+95.55 (+36.74%)
since 10/11/23

Most Recent Stories

More News
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions,...

ZBH : 103.50 (+0.66%)
SNN : 28.41 (-0.46%)
SYK : 355.60 (+0.63%)
MDT : 89.36 (+0.57%)
Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon

Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy?

SYK : 355.60 (+0.63%)
MDT : 89.36 (+0.57%)
ISRG : 484.78 (+0.19%)
Stryker Stock Gains 18.6% YTD: What's Driving its Share Price?

Stryker Corporation SYK has witnessed substantial gains in the year-to-date period. Shares of the company have rallied 18.6% compared with 13.4% growth of the industry. The S&P 500 Composite has risen...

UHS : 214.33 (+0.67%)
DGX : 148.67 (+0.58%)
SYK : 355.60 (+0.63%)
BAX : 36.54 (-1.32%)
Reasons to Retain Stryker Stock in Your Portfolio for Now

Stryker Corporation SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism.Shares...

UHS : 214.33 (+0.67%)
SYK : 355.60 (+0.63%)
AZPN : 235.86 (+2.00%)
DVA : 160.85 (+0.89%)
Stryker Stock Declines Despite Completion of care.ai Acquisition

Stryker Corporation SYK announced that it has closed the previously-announced agreement to acquire care.ai, a privately held company specializing in artificial intelligence (AI)-assisted virtual care workflows,...

BSX : 87.10 (+1.04%)
BAX : 36.54 (-1.32%)
SYK : 355.60 (+0.63%)
DVA : 160.85 (+0.89%)
SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio

Stryker SYK recently announced the expansion of its Foot & Ankle portfolio with the introduction of two cutting-edge products — the Osteotomy Truss System (“OTS”) and the Ankle Truss System (“ATS”)....

BSX : 87.10 (+1.04%)
DGX : 148.67 (+0.58%)
SYK : 355.60 (+0.63%)
DVA : 160.85 (+0.89%)
Stryker - Growth Through Aggressive M&A

Summary Stryker Corporation (SYK) shows strong technical buy signals, with a 6.09% gain since 8/21, and consistent price appreciation across key moving averages. The company operates in MedSurg, Neurotechnology,...

SYK : 355.60 (+0.63%)
Stryker Stock: Is SYK Outperforming the Healthcare Sector?

Despite Stryker’s outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

SYK : 355.60 (+0.63%)
XLV : 153.89 (+0.73%)
BDX : 236.50 (+0.41%)
How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks?

Medtronic has lagged behind other medical device stocks over the past months, yet Wall Street remains moderately bullish on the stock’s prospects.

MDT : 89.36 (+0.57%)
MDT : 89.36 (+0.57%)
IHI : 58.61 (+0.43%)
SYK : 355.60 (+0.63%)
This Is Great News for Medtronic, but Is It Time to Buy the Stock?

This MedTech leader is back on track with profitable growth.

ABT : 116.12 (+0.43%)
SYK : 355.60 (+0.63%)
EW : 68.13 (-0.19%)
BSX : 87.10 (+1.04%)
GEHC : 91.03 (+0.86%)
MDT : 89.36 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products...

See More

Key Turning Points

3rd Resistance Point 364.61
2nd Resistance Point 361.74
1st Resistance Point 358.67
Last Price 355.60
1st Support Level 352.73
2nd Support Level 349.86
3rd Support Level 346.79

See More

52-Week High 374.63
Last Price 355.60
Fibonacci 61.8% 327.01
Fibonacci 50% 312.30
Fibonacci 38.2% 297.60
52-Week Low 249.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar